SCHEMBL7703136

SCHEMBL7703136

[c]1ccc(Oc2ccccc2)cc1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.46
TSHR P16473 1/20 0.46
MAOB P27338 2/20 0.42
GSTP1 P09211 1/20 0.40
AKR1C3 P42330 1/20 0.39
MAOA P21397 2/20 0.38
NR1H2 P55055 1/20 0.38
BAX Q07812 1/20 0.38
KDR P35968 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
FABP1 P07148 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8529939 0.94 GSTP1 (0.47) LTA4HTSHRMAOBGSTP1AKR1C3
SCHEMBL8315326 0.93 MAOB (0.44) LTA4HTSHRMAOBGSTP1AKR1C3
SCHEMBL16719650 0.88 NOTUM (0.39) LTA4HTSHRMAOBGSTP1SMN1; SMN2
SCHEMBL16719443 0.87 PGR (0.40) LTA4HTSHRMAOBGSTP1AKR1C3
SCHEMBL10965408 0.85 GSTP1 (0.37) LTA4HTSHRMAOBGSTP1AKR1C3
SCHEMBL16719819 0.85 LTA4H (0.42) LTA4HTSHRMAOBAKR1C3NR1H2
SCHEMBL8531326 0.84 LTA4H (0.53) LTA4HTSHRGSTP1SMN1; SMN2CYP1A2
SCHEMBL7795502 0.84 KIF11 (0.44) LTA4HTSHRCYP1A2CYP2C9CYP2C19
SCHEMBL6848644 0.84 KIF11 (0.44) LTA4HTSHRCYP1A2CYP2C9CYP2C19
SCHEMBL7703865 0.84 GSTP1 (0.44) LTA4HTSHRGSTP1MAOANR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3068758-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE The Wistar Institute Of Anatomy And Biology (US) 2016-09-21 EP disclosed
WO-2015073864-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE THE WISAR INSTITUTE OF ANATOMY AND BIOLOGY (US) 2015-05-21 WO disclosed
EP-1216285-A1 FLUORESCENT MALEIMIDES AND USES THEREOF Ciba SC Holding AG (CH) 2002-06-26 EP disclosed
WO-2001019939-A1 FLUORESCENT MALEIMIDES AND USES THEREOF CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-03-22 WO disclosed
EP-1028945-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS Amgen Inc. (US) 2000-08-23 EP disclosed
WO-1999024404-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC. (US) 1999-05-20 WO disclosed